Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

Abstract Background In patients undergoing major liver resection, portal vein embolization (PVE) has been widely used to induce hypertrophy of the non-embolized liver in order to prevent post-hepatectomy liver failure. PVE is a safe and effective procedure, but does not always lead to sufficient hyp...

Full description

Bibliographic Details
Main Authors: Emmanuel Deshayes, Lauranne Piron, Antoine Bouvier, Bruno Lapuyade, Emilie Lermite, Laurent Vervueren, Christophe Laurent, Jean-Baptiste Pinaquy, Patrick Chevallier, Anthony Dohan, Agnès Rode, Christian Sengel, Chloé Guillot, François Quenet, Boris Guiu
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Cancer
Subjects:
Liver metastases
Portal vein embolization
Venous deprivation
Major hepatectomy
Colo-rectal cancer
Online Access:http://link.springer.com/article/10.1186/s12885-020-07065-z

Internet

http://link.springer.com/article/10.1186/s12885-020-07065-z

Similar Items